UOC
CRL icon

UBS O'Connor’s Charles River Laboratories CRL Stock Holding History

UBS O'Connor’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,034
Closed -$481K – 549
2023
Q4 		$481K Sell
2,034
-1,177
-37% -$231K 0.02% 355
2023
Q3 		$629K Hold
3,211
– – 0.01% 376
2023
Q2 		$675K Buy
3,211
+158
+5% +$31.4K 0.01% 420
2023
Q1 		$616K Buy
+3,053
New +$692K 0.01% 447
2015
Q1 		– Sell
-3,440
Closed -$219K – 747
2014
Q4 		$219K Buy
+3,440
New +$216K ﹤0.01% 593

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return